Atlas Trials

Open Label Immunotherapy Trial for Breast Cancer

Clinical trial NCT03572361 · UNKNOWN

Trial details

NCT number
NCT03572361
Sponsor
Immunitor LLC
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2018-07-01
Primary completion
2019-11-30
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.